A Systematic Review of Predictors of Vaping Cessation Among Young People
Individual Clinical
Safety
Adverse Effects
Kundu (2025)
Effects of Very Low Nicotine Content Cigarettes and Nicotine Vaping Device Characteristics on Choices to Smoke, Vape, or Abstain in Early Young Adults
Individual Clinical
User Topography
Cassidy (2025)
The Impact of Three Alternate Nicotine-Delivery Products on Combusted Cigarette Use: A Randomized Controlled Trial
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Piper (2025)
Switching to E-cigarettes as Harm Reduction Among Individuals With Chronic Disease Who Currently Smoke: Results of a Pilot Randomized Controlled Trial
Individual Clinical
Safety
Adverse Effects
Vojjala (2025)
Use of Cigarettes and E-Cigarettes, Impulsivity, and Anxiety: Influences on Suicidal Ideation Among Youth and Young Adults in Texas
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Wilkinson (2025)
Personal Characteristics Associated With Switching From Cigarettes to Noncombustible Tobacco and Nicotine Products Among U.S. Adults: Findings From PATH Study Waves 1–5
Individual Clinical
User Topography
Sharma (2025)
A Content Analysis of Nicotine Descriptors on the Front of Vape Packaging in the United Kingdom
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ford (2025)
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Azzopardi (2022)
A Novel Nicotine Sublingual Tablet which Mimics Cigarette Smoking Pharamceuticals
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McCarty (2015)
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Dautzenberg et al (2007)